Radiation Proctitis Treatment Market

Radiation Proctitis Treatment Market Overview

Radiation proctitis is a complication which occurs after a radiation therapy for treatment of pelvic malignancy. Most of the cases of radiation proctitis are treated without surgery. The complication involves inflammation of the lower part of the colon, apoptosis, damage of DNA, proteins among many more complications. The most common symptom of radiation proctitis is rectal bleeding.

The COVID-19 pandemic has caused ripples in all the industrial sectors including healthcare. The effects of this on the global radiation proctitis treatment market would also be felt.

The effects however, might not be hugely impactful. Some effects could be suspension of manufacturing process, delay in raw material procurement, delay in supply chain logistics, shortage of labor. COVID-19 burden on the hospitals might also result in various effects like diversion of funds and staff to deal with COVID patients which would eventually affect the global radiation proctitis treatment market.

Radiation Proctitis Treatment Market: Drivers and Restraints

The major driver for the global radiation proctitis treatment market if the growing prevalence of rectal, prostate and cervical cancer. Another driver in the market of radiation proctitis treatment is growing adoption of radiation therapy to treat the above mentioned conditions.

Various collaborations to investigate better treatment options for prostate, rectal or cervical cancer may in long run hamper the growth of global radiation proctitis treatment market. Lack of awareness and resources in the developing world would further add to the restraints for the global radiation proctitis treatment market.

Radiation Proctitis Treatment Market: Overview

The global radiation proctitis treatment market is set to register robust growth owing to the increased incidences of various cancers like cervical, prostate, and rectal. Prostate cancer is the second most common cancer and is fifth most cause of death in the world.

Based on the type segmentation, sucralfate drugs sub-segment is expected to register robust growth in the radiation proctitis treatment market, as these contain high sulfated polyanionic disaccharide compound resulting in epithelial healing and forming a coat that facilitates quick healing. Based on the distribution channel, hospital pharmacies can be estimated to hold the majority of share in the global radiation proctitis treatment market since these drugs are mostly taken under medical supervision.

Radiation Proctitis Treatment Market: Region-wise Outlook

North America can be estimated to dominate the global radiation proctitis treatment market based on high prevalence of rectal cancer and prostate in the region. Europe may be estimated to hold the second major share in the global market of radiation proctitis treatment.

This is based on the fact that the incidence rate of prostate cancer in the region is 62.1%. Middle East and Africa is expected to hold least share in the global radiation proctitis treatment market. Increase in radiation therapy for cancer treatment in the regions of Asia is expected to boost the global radiation proctitis treatment market in the region.

Radiation Proctitis Treatment Market: Key Players

The key players for the global radiation proctitis treatment market are

• Dr. Reddy Laboratories,
• Chugai Pharmaceutical Co Ltd.,
• Nanjing Pharmaceutical Factory Co., Ltd.,
• GlaxoSmithKline,
• Allergan,
• Northeast Pharmaceutical,
• Reckitt & Benckiser,
• Huanan Pharma
• Sun Pharmaceutical Industries

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Indication
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Europe (Germany, U.K, France, Italy, Spain)
• South Asia (India, ASEAN Countries)
• East Asia (Japan, China & South Korea)
• Oceania (Australia & New Zealand)
• Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Radiation Proctitis Treatment Market: Segmentation

The international radiation proctitis treatment market is segmented based on indication, therapy, type, route of administration, distribution channel and region.

By Indication :

• Acute Radiation Proctitis
• Chronic Radiation Proctitis

By Therapy :

• Oral Therapy
• Rectal Instillation Therapy
• Thermal Therapy
• Hyperbaric Oxygen Therapy

By Type :

• Non-Invasive
  • Non-Steroidal Anti-Inflammatory Drugs,
  • Sucralfate
  • Short-Chain Fatty Acids (Scfa)
  • Hyperbaric Oxygen (Hbo)
  • Antioxidants
• Invasive

By Route of Administration :

• Oral
• Intravenous

By Distribution Channel :

• Hospital Pharmacies
• Drug Stores
• Retail Pharmacies
• Online Pharmacies